NASDAQ:SRPT - Sarepta Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$118.09 +4.30 (+3.78 %)
(As of 04/24/2019 06:00 AM ET)
Previous Close$113.79
Today's Range$112.54 - $118.3260
52-Week Range$74.51 - $176.50
Volume1.31 million shs
Average Volume1.33 million shs
Market Capitalization$8.42 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.04

Analyst Ratings

Sarepta Therapeutics (NASDAQ:SRPT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
28 Wall Street analysts have issued ratings and price targets for Sarepta Therapeutics in the last 12 months. Their average twelve-month price target is $195.0476, suggesting that the stock has a possible upside of 65.17%. The high price target for SRPT is $270.00 and the low price target for SRPT is $121.00. There are currently 2 hold ratings and 26 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.932.932.922.92
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
26 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
25 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
23 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
23 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $195.0476$193.90$184.2857$169.3414
Price Target Upside: 65.17% upside44.28% upside52.39% upside39.42% upside

Sarepta Therapeutics (NASDAQ:SRPT) Consensus Price Target History

Price Target History for Sarepta Therapeutics (NASDAQ:SRPT)

Sarepta Therapeutics (NASDAQ:SRPT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/17/2019BTIG ResearchSet Price TargetBuy$190.00HighView Rating Details
4/11/2019Evercore ISIInitiated CoverageOutperform$175.00HighView Rating Details
3/31/2019CowenReiterated RatingBuy$213.00LowView Rating Details
3/28/2019Piper Jaffray CompaniesBoost Price TargetOverweight$200.00 ➝ $208.00LowView Rating Details
3/12/2019BMO Capital MarketsInitiated CoverageOutperformLowView Rating Details
3/11/2019Credit Suisse GroupReiterated RatingOutperform ➝ Outperform$189.00 ➝ $207.00LowView Rating Details
3/5/2019Svb LeerinkReiterated RatingOutperformLowView Rating Details
3/4/2019Morgan StanleyBoost Price TargetOverweight ➝ Overweight$161.00 ➝ $169.00LowView Rating Details
3/1/2019CitigroupBoost Price TargetBuy ➝ Buy$188.00 ➝ $201.00LowView Rating Details
2/28/2019NomuraBoost Price TargetBuy ➝ Buy$205.00 ➝ $230.00LowView Rating Details
2/28/2019Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$217.00 ➝ $231.00HighView Rating Details
2/27/2019JMP SecuritiesReiterated RatingBuy$270.00HighView Rating Details
1/17/2019Royal Bank of CanadaReiterated RatingOutperform$164.00LowView Rating Details
1/8/2019Janney Montgomery ScottSet Price TargetBuy$200.00MediumView Rating Details
1/4/2019HC WainwrightSet Price TargetBuy$267.00HighView Rating Details
10/12/2018Sanford C. BernsteinInitiated CoverageOutperform$170.00HighView Rating Details
9/24/2018Needham & Company LLCLower Price TargetBuy$196.00LowView Rating Details
9/14/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$199.00LowView Rating Details
6/22/2018SunTrust BanksBoost Price TargetBuy$176.00HighView Rating Details
6/21/2018Robert W. BairdReiterated RatingOutperform ➝ Outperform$120.00 ➝ $202.00MediumView Rating Details
6/20/2018WBB SecuritiesReiterated RatingBuyLowView Rating Details
6/20/2018Leerink SwannReiterated RatingOutperform ➝ OutperformHighView Rating Details
6/20/2018BarclaysReiterated RatingOverweight$180.00HighView Rating Details
6/19/2018William BlairReiterated RatingBuyHighView Rating Details
6/19/2018JPMorgan Chase & Co.Reiterated RatingOverweightHighView Rating Details
5/18/2018Goldman Sachs GroupBoost Price TargetBuy$84.00 ➝ $127.00LowView Rating Details
5/4/2018OppenheimerDowngradeOutperform ➝ Market PerformHighView Rating Details
5/4/2018UBS GroupDowngradeOutperform ➝ Market PerformHighView Rating Details
10/2/2017InstinetReiterated RatingBuy$84.00LowView Rating Details
(Data available from 4/24/2017 forward)
This page was last updated on 4/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel